RYAN CRAYCRAFT: Open Payments
NPI 1801283981 · DAYTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,175 in 50 payments from 15 companies in 2025. Trend: 2023 $654 · 2024 $1,035 · 2025 $1,175
Food & beverage: $1,175
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $295 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $141 |
| Janssen Biotech, Inc. | 6 | $129 |
| PFIZER INC. | 5 | $123 |
| Regeneron Healthcare Solutions, Inc. | 3 | $83 |
| Aimmune Therapeutics, Inc. | 2 | $65 |
| QOL Medical, LLC | 2 | $60 |
| Gilead Sciences, Inc. | 3 | $51 |
| Lilly USA, LLC | 2 | $48 |
| Ardelyx, Inc. | 2 | $48 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, XELJANZ, EOHILIA, VOWST, RINVOQ, MAVYRET.
Industry payments across OH — which companies pay providers there.
